WPHARMA
ActiveSummary
WPHARMA has been active since 2008 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €688,259 and a net result of €47,204. Equity is growing by about 8.8% per year across the filed financial years. Its solvency ranks better than 68% of 10,757 sector peers (NACE 70, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
History
Acts, filings and financial milestones
28-08
Gazette deed
Legal-form change · Resignations & appointmentsAppointment: Wendy Pauwels (director) · Incorporation · Amendment of the articles12 facts ▸
- General meeting, 25-07-2023
- Other provision, “2880Bornem,Riddermoerstraat4, registerinschrijving” (deed in Dutch)
- Incorporation, 30-05-2008
- Other provision, “statutenwijziging, niet gewijzigd tot op heden” (deed in Dutch)
- Amendment of the articles (2 times)
- Capital conversion, “van rechtswege omgezet, Tweede beslissing” (deed in Dutch)
- Reserve release, “integrale opheffing aangelegde statutair onbeschikbare eigen vermogensrekeningen, onmiddellijk” (deed in Dutch)
- Director appointment, Wendy Pauwels (director)
- Capital
- Power of attorney, Tim VANDERSTEEN
- Power of attorney
- Other provision, “stemming, alle voorafgaande beslissingen met eenparige stemmen” (deed in Dutch)
About the unread acts
Of the 3 Belgian Official Gazette deeds we know for this company, 1 has been read. The other 2 have not been read yet: what they contain is neither established nor disproved here.